Literature DB >> 8384836

Interleukin-1 alpha induces a sustained increase in cytosolic free calcium in cultured rabbit osteoclasts.

H Yu1, J Ferrier.   

Abstract

Using laser confocal microscopy and a Ca2+ indicator, fluo-3, we find that osteoclasts respond to IL-1 alpha with a sustained increase (4 to 40 min) in cytosolic free calcium ([Ca2+]i). The delay time (T1/2) varies from 2 to 8 minutes. These effects cannot be mimicked by application of cAMP and can be blocked by removal of Ca2+ from the bathing medium. Pre-incubation with indomethacin (30 microM) does not block the IL-1 alpha effect on [Ca2+]i. We employ a 'micropipette' method and a 'pieces of cover slip' method to isolate single osteoclasts. Our results provide evidence that IL-1 alpha directly stimulates osteoclasts via a [Ca2+]i signalling pathway. We postulate that this slowly developing, long-lasting increase in [Ca2+]i in osteoclasts may account for the stimulatory effect of IL-1 alpha on osteoclastic bone resorption in conjunction with signalling molecules from osteoblasts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384836     DOI: 10.1006/bbrc.1993.1223

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells.

Authors:  T Sunyer; J Lewis; P Collin-Osdoby; P Osdoby
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

2.  The anti-inflammatory role of vitamin e in prevention of osteoporosis.

Authors:  A S Nazrun; M Norazlina; M Norliza; S Ima Nirwana
Journal:  Adv Pharmacol Sci       Date:  2011-11-17

3.  Stimulatory effect of interleukin-1 alpha on proliferation through a Ca2+/calmodulin-dependent pathway of a human thyroid carcinoma cell line, NIM 1.

Authors:  N Inokuchi; K Zeki; I Morimoto; Y Nakano; T Fujihira; U Yamashita; N Yanagihara; F Izumi; S Eto
Journal:  Jpn J Cancer Res       Date:  1995-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.